BenevolentAI Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BenevolentAI Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12378
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BenevolentAI Ltd (BenevolentAI) is an artificial intelligence company that focuses on developing and applying artificial intelligence (AI) to produce new medicines for the treatment of diseases with unmet medical needs. The company’s platform enables scientists to design and develop new treatments for patients, using a large amount of extracted and deduced biomedical information. BenevolentAI has capabilities spanning the entire drug development process from early drug discovery to late stage clinical development. The company harnesses AI technology to focus on developing treatments for a wide range of diseases such as glioblastoma, motor neuron disease, sarcopenia and Parkinson’s disease. It has presence in the UK, Belgium and the US. BenevolentAI is headquartered in London, the UK.

BenevolentAI Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BenevolentAI Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Benevolentai Acquires Cambridge Research Facility from Proximagen 10
Venture Financing 11
BenevolentAI Secures USD115 Million in Venture Financing 11
Partnerships 12
Axxam and Proximagen Enter into Partnership 12
BenevolentAI Partners with MRC Technology 13
Licensing Agreements 14
BenevolentAI Enters into Licensing Agreement with Janssen Pharma 14
F. Hoffmann-La Roche Entered into Licensing Agreement with Proximagen 15
Asset Transactions 16
Benevolentai Acquires Cambridge Research Facility from Proximagen 16
BenevolentAI Ltd – Key Competitors 17
BenevolentAI Ltd – Key Employees 18
BenevolentAI Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Government and Public Interest 20
Nov 09, 2017: BenevolentAI: Annual award announced for medical research charities wishing to benefit from artificial intelligence 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Key Facts 2
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BenevolentAI Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BenevolentAI Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Benevolentai Acquires Cambridge Research Facility from Proximagen 10
BenevolentAI Secures USD115 Million in Venture Financing 11
Axxam and Proximagen Enter into Partnership 12
BenevolentAI Partners with MRC Technology 13
BenevolentAI Enters into Licensing Agreement with Janssen Pharma 14
F. Hoffmann-La Roche Entered into Licensing Agreement with Proximagen 15
Benevolentai Acquires Cambridge Research Facility from Proximagen 16
BenevolentAI Ltd, Key Competitors 17
BenevolentAI Ltd, Key Employees 18
BenevolentAI Ltd, Other Locations 19
BenevolentAI Ltd, Subsidiaries 19

List of Figures
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BenevolentAI Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[BenevolentAI Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mazda Motor Corporation:企業の戦略・SWOT・財務分析
    Mazda Motor Corporation - Strategy, SWOT and Corporate Finance Report Summary Mazda Motor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Taylor-DeJongh Inc:企業の戦略・SWOT・財務分析
    Taylor-DeJongh Inc - Strategy, SWOT and Corporate Finance Report Summary Taylor-DeJongh Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Taisho Pharmaceutical Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Expeditors International of Washington, Inc.:企業の戦略・SWOT・財務分析
    Expeditors International of Washington, Inc. - Strategy, SWOT and Corporate Finance Report Summary Expeditors International of Washington, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Zanders GmbH:企業の戦略的SWOT分析
    Zanders GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • JHL Biotech Inc:医療機器:M&Aディール及び事業提携情報
    Summary JHL Biotech Inc (JHL Biotech) is a biologic medicines provider. The company offers cell line construction, process development, manufacturing, quality and regulatory services. It offers products such as biosimilar rituximab, biosimilar dornase alfa, biosimilar bevacizumab, biosimilar trastuz …
  • DIA Imaging Analysis Ltd:医療機器:M&Aディール及び事業提携情報
    Summary DIA Imaging Analysis Ltd (DIA Imaging Analysis), formerly DiACardio Ltd is a provider of medical imaging solutions. The company’s products comprise LVivo SWM, LVivo EF, and LVivo Strain. Its LVivo SWM is a fully automated echo device or PACS systems. DiACardio’s LVivo platform comprises tool …
  • UPL Ltd (UPL):企業の財務・戦略的SWOT分析
    UPL Ltd (UPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • General Motors Co (GM):企業の財務・戦略的SWOT分析
    General Motors Co (GM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • BioMarker Strategies LLC-医療機器分野:企業M&A・提携分析
    Summary BioMarker Strategies LLC (BioMarker Strategies) is a biotechnology company that develops tissue-based cancer diagnostic systems. The company offers cancer diagnostics system for predictive tests to targeted treatments for solid tumor malignancies. It also offers pathmap functional signaling …
  • BioVendor – Laboratorni Medicina as:製薬・医療:M&Aディール及び事業提携情報
    Summary BioVendor - Laboratorni Medicina as (BioVendor) is a developer and manufacturer of immunoassays, recombinant protiens, antibodies and endotoxin-removal products. The company provides products such as immunoassays, proteins, antibodies, endotoxin removal products, endotoxin detection products …
  • Union Jack Oil plc (UJO):企業の財務・戦略的SWOT分析
    Summary Union Jack Oil Plc (Union Jack Oil), formerly Union Jack Oil Ltd is an onshore oil and gas company that offers exploration and development of hydrocarbon projects. The company develops its portfolio of oil and gas assets by acquiring interests in drill ready prospects. It holds license inter …
  • Texas Instruments Incorporated:企業の戦略・SWOT・財務情報
    Texas Instruments Incorporated - Strategy, SWOT and Corporate Finance Report Summary Texas Instruments Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • DiGi.Com Berhad (DIGI):企業の財務・戦略的SWOT分析
    DiGi.Com Berhad (DIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Schindler Holding Ltd.:企業の戦略・SWOT・財務分析
    Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Dorchester Minerals LP Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive info …
  • IV Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary IV Diagnostics Inc (IV Diagnostics) is a biomedical company that offers research services. The company conducts molecular diagnostic tests for circulating tumor cells and other blood borne diseases. It develops, tests and markets diagnostic tools that monitor and measure cancer tumor cells. …
  • Ssangyong Cement Industrial Co., Ltd.:企業の戦略・SWOT・財務情報
    Ssangyong Cement Industrial Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ssangyong Cement Industrial Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Maxion Wheels Inc:企業の戦略的SWOT分析
    Maxion Wheels Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Scienion AG:製品パイプライン分析
    Summary Scienion AG (Scienion) is a life science company that offers solutions for liquid dispensing applications. The company’s products include scireader cl, innoscan microarray scanners, sciflexarrayer, sciliner lateral flow dispenser, sciconsumables- sciplexplates 96, scichip, scibuffer, scihybc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆